Sunvozertinib monotherapy in EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancer with EGFR mutations. Wang M, Xu Y, Huang WT, Su WC, et al. Lung Cancer 2024;199:108053.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang M, Xu Y, Huang WT, Su WC, et al. Sunvozertinib monotherapy in EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancer with EGFR mutations. Lung Cancer 2024;199:108053.
PMID: 39647463